Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH-SC01 cell injection for Crohn's disease perianal fistula (phase II, randomized, double-blind, placebo-controlled)
CTR20223296Phase 2Active
- Sponsor
- T-Hone Biotech
- Start
- Feb 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of TH-SC01 in Perianal Crohn's fistula (pCF), sponsored by T-Hone Biotech. Started Feb 2023; status: active.
02
Drugs
TH-SC01
03
Conditions
Perianal Crohn's fistula (pCF)
Beyond the preview
Go deeper on CTR20223296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223296.